Single-dose Study to Evaluate the Absolute Bioavailability and Mass Balance of ONO-5788
Status:
Completed
Trial end date:
2019-04-02
Target enrollment:
Participant gender:
Summary
A phase 1 healthy volunteer study to assess the excretion and metabolism as well as the
absolute bioavailability of oral ONO-5788. The study will be conducted in two parts: Part 1
to assess the absolute bioavailability using ONO-5788 and radiolabelled ONO-5788 as
intravenous and oral forms; part 2 will assess the mass balance of ONO-5788 using orally
administered radiolabelled ONO-5788